Literature DB >> 30511386

Intracranial pressure during hemodialysis in patients with acute brain injury.

Anton Lund1, Mette B Damholt2, Jørgen Wiis3, Jesper Kelsen4, Ditte G Strange1, Kirsten Møller1.   

Abstract

BACKGROUND: Because osmotic fluid shifts may occur over the blood-brain barrier, patients with acute brain injury are theoretically at risk of surges in intracranial pressure (ICP) during hemodialysis. However, this remains poorly investigated. We studied changes in ICP during hemodialysis in such patients.
METHODS: We performed a retrospective study of patients with acute brain injury admitted to Rigshospitalet (Copenhagen, Denmark) from 2012 to 2016 who received intermittent hemodialysis (IHD) or continuous renal replacement therapy (CRRT) while undergoing ICP monitoring. Data from each patient's first dialysis session were collected. Area under the curve divided by time (AUC/t) for ICP was calculated separately before and during dialysis.
RESULTS: Thirteen patients were included. During dialysis, ICP increased from a baseline of 11.9 mm Hg (median; interquartile range 6.3-14.7) to a maximum of 21 mm Hg (18-27) (P = 0.0024), and AUC/t for ICP was greater during dialysis (15.2 (13.4-18.8) vs 11.7 mm Hg (6.4-15.1), P = 0.042). The maximum ICP increase was independent of dialysis modality, but peak values were reached earlier in patients treated with IHD (N = 4) compared to CRRT (N = 9) (75 [30-90] vs 375 min [180-420] after start of treatment, P = 0.0095). The maximum ICP increase correlated positively to the baseline plasma urea concentration (Spearman's r = 0.69, P = 0.017).
CONCLUSION: Hemodialysis is associated with increased ICP in neurocritically ill patients, and the magnitude of the increase may be related to initial plasma urea levels.
© 2018 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute brain injury; cerebral edema; continuous renal replacement therapy; dialysis disequilibrium syndrome; hemodialysis; intracranial pressure; renal replacement therapy

Mesh:

Substances:

Year:  2018        PMID: 30511386     DOI: 10.1111/aas.13298

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

1.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

2.  The Relationship between Cerebrovascular Reactivity and Cerebral Oxygenation during Hemodialysis.

Authors:  Wesley T Richerson; Brian D Schmit; Dawn F Wolfgram
Journal:  J Am Soc Nephrol       Date:  2022-07-01       Impact factor: 14.978

Review 3.  Dialysis disequilibrium syndrome (DDS) in pediatric patients on dialysis: systematic review and clinical practice recommendations.

Authors:  Rupesh Raina; Andrew Davenport; Bradley Warady; Prabhav Vasistha; Sidharth Kumar Sethi; Ronith Chakraborty; Prajit Khooblall; Nirav Agarwal; Manan Vij; Franz Schaefer; Kunal Malhotra; Madhukar Misra
Journal:  Pediatr Nephrol       Date:  2021-10-05       Impact factor: 3.714

4.  The CSF Diversion via Lumbar Drainage to Treat Dialysis Disequilibrium Syndrome in the Critically Ill Neurological Patient.

Authors:  Christopher S Hong; Kevin Wang; Guido J Falcone
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.